These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 7149615)
1. Histopathological malignancy grading and familiality in an unselected series of 1303 women with breast carcinoma. Adami HO; Jung B; Lindgren A; Rimsten A Ann Clin Res; 1982 Apr; 14(2):76-82. PubMed ID: 7149615 [TBL] [Abstract][Full Text] [Related]
2. Clinical findings in relation to morphology in breast carcinoma. Rimsten A; Stenkvist B; Lindgren A Ann Clin Res; 1975 Apr; 7(2):89-100. PubMed ID: 1181980 [TBL] [Abstract][Full Text] [Related]
3. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth]. van der Loo EM; Hop WC; Tervoort MA; de Graaf PW Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561 [TBL] [Abstract][Full Text] [Related]
4. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma. Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808 [TBL] [Abstract][Full Text] [Related]
5. Breast carcinoma in Pakistani women. Usmani K; Khanum A; Afzal H; Ahmad N J Environ Pathol Toxicol Oncol; 1996; 15(2-4):251-3. PubMed ID: 9216816 [TBL] [Abstract][Full Text] [Related]
6. [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer]. Ouyang T; Li JF; Wang TF; Lin BY Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):298-300. PubMed ID: 15842936 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997 [TBL] [Abstract][Full Text] [Related]
9. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens. Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950 [TBL] [Abstract][Full Text] [Related]
10. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance]. Nzengue JC; Zhan WH; Wang JP; Dong WG; Lan P; He YL; Chen ZX; Cai SR Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796 [TBL] [Abstract][Full Text] [Related]
11. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma. Kuru B; Bozgul M Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505 [TBL] [Abstract][Full Text] [Related]
12. Axillary lymph node metastases associated with small invasive breast carcinomas. Maibenco DC; Weiss LK; Pawlish KS; Severson RK Cancer; 1999 Apr; 85(7):1530-6. PubMed ID: 10193943 [TBL] [Abstract][Full Text] [Related]
13. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial. Christensen SB; Jansson C Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890 [TBL] [Abstract][Full Text] [Related]
14. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature. Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092 [TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible? Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428 [TBL] [Abstract][Full Text] [Related]
16. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome. Nassar A; Cohen C; Cotsonis G; Carlson G Breast J; 2008; 14(2):147-52. PubMed ID: 18248563 [TBL] [Abstract][Full Text] [Related]
17. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system. Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A Breast J; 2006; 12(4):294-301. PubMed ID: 16848838 [TBL] [Abstract][Full Text] [Related]
18. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer. Fink AM; Lass H; Hartleb H; Jurecka W; Salzer H; Steiner A Ann Surg Oncol; 2008 Mar; 15(3):848-53. PubMed ID: 18043975 [TBL] [Abstract][Full Text] [Related]
19. Significance of micrometastases on the survival of women with T1 breast cancer. Maibenco DC; Dombi GW; Kau TY; Severson RK Cancer; 2006 Sep; 107(6):1234-9. PubMed ID: 16900518 [TBL] [Abstract][Full Text] [Related]
20. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up. Reed W; Bøhler PJ; Sandstad B; Nesland JM Breast J; 2004; 10(3):174-80. PubMed ID: 15125740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]